ReviewJournal of exercise rehabilitation2016
Let's rethinking about the safety of phosphodiesterase type 5 inhibitor in the patients with erectile dysfunction after radical prostatectomy.
Su Jin Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.